Princeton Bancorp, Inc.
BPRNNasdaqCIK 1913971FinancialsFiscal year ends Dec 31
Reports and events: 74 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-01-1816:16 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-010211 |
| 2024-01-1808:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-009703 |
| 2023-11-1312:42 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001193125-23-275720 |
| 2023-10-2616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-264060 |
| 2023-10-2516:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-263003 |
| 2023-08-1416:40 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001193125-23-212421 |
| 2023-08-1009:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-208232 |
| 2023-07-2716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-196069 |
| 2023-07-2016:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-190484 |
| 2023-05-2217:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-149542 |
| 2023-05-1116:57 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001193125-23-142133 |
| 2023-05-0208:31 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-131392 |
| 2023-04-2016:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-108290 |
| 2023-04-1916:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-106531 |
| 2023-04-0307:00 ET | DEF 14A | Proxy statementPeriod 2023-04-28 | 0001193125-23-088889 |
| 2023-03-2416:48 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001193125-23-079231 |
| 2023-01-2616:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-016226 |
| 2023-01-2516:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-015169 |
| 2022-11-1013:50 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001193125-22-282379 |
| 2022-09-0216:34 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-22-237952 |
| 2022-08-1216:18 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001193125-22-219957 |
| 2022-05-1315:36 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001193125-22-150010 |
| 2022-05-0417:16 ET | 8-K | 8.01 Other events | 0001193125-22-140600 |
| 2022-04-1506:07 ET | 8-K | 8.01 Other events | 0001193125-22-106119 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 14:21 ET. Listed shows no prices and gives no investment advice.